ID:4007 Immune-cell base for cancer therapy
نویسندگان
چکیده
منابع مشابه
NK cell-based autologous immune enhancement therapy (AIET) for cancer
Natural killer (NK) cells have been known to enhance the host immune responses against cancer. NK cell number and cytotoxicity in patients with cancer is often low. Therefore, we developed a large-scale ex vivo NK cell expansion method without feeder layers and introduced NK cell-based autologous immune enhancement therapy (AIET). In this paper, we discuss the epidemiological data that show the...
متن کاملImmune Therapy for Breast Cancer
In breast cancer, components of the immune system are thought to play important roles in several parts of the metastatic cascade 2. Various immune strategies have been tested as therapy for breast cancer: vaccine therapy, administration of exogenous cytokines, monoclonal antibodies, and gene therapy. As a guide to the practicing clinician, the present article reviews current progress and future...
متن کاملBase excision repair targets for cancer therapy.
Cellular DNA repair is a frontline system that is responsible for maintaining genome integrity and thus preventing premature aging and cancer by repairing DNA lesions and strand breaks caused by endogenous and exogenous mutagens. However, it is also the principal cellular system in cancer cells that counteracts the killing effect of the major cancer treatments e.g. chemotherapy and ionizing rad...
متن کاملImmune checkpoint therapy for pancreatic cancer
Novel treatment modalities are necessary for pancreatic cancer. Immunotherapy with immune checkpoint inhibition has shown effect in other solid tumors, and could have a place in pancreatic cancer treatment. Most available clinical studies on immune checkpoint inhibitors for pancreatic cancer are not yet completed and are still recruiting patients. Among the completed trials, there have been fin...
متن کاملLow pH preconditioned amniotic epithelial cells for stem cell therapy of cancer
Amniotic epithelial cells (AECs) possess unique characteristics, which make them a suitable source for cell-based therapeutic strategies. AECs have stem cell properties with low-immunogenicity (due to expressing HLA-G molecule and absence of MHC class I and II antigens) and no ethical problems, as well as availability in sufficient numbers, which can be obtained from a placenta. We have recentl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedical Research and Therapy
سال: 2017
ISSN: 2198-4093,2198-4093
DOI: 10.15419/bmrat.v4is.217